Authors' Reply: Clarifying Blood Indices in Patients With Ovarian Cancer.
作者信息
Zhang Jiahua
机构信息
Ward 2, Gynaecological Oncology Centre, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China, 86 13582506099.
出版信息
JMIR Mhealth Uhealth. 2025 Aug 13;13:e74931. doi: 10.2196/74931.
Abstract
摘要
相似文献
1
Authors' Reply: Clarifying Blood Indices in Patients With Ovarian Cancer.作者回复：澄清卵巢癌患者的血液指标。
JMIR Mhealth Uhealth. 2025 Aug 13;13:e74931. doi: 10.2196/74931.
2
Clarifying Blood Indices in Patients With Ovarian Cancer.阐明卵巢癌患者的血液指标
JMIR Mhealth Uhealth. 2025 Aug 13;13:e70895. doi: 10.2196/70895.
3
Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial.基于微信的多学科全程营养管理方案对化疗卵巢癌患者营养状况的影响：随机对照试验。
JMIR Mhealth Uhealth. 2024 Nov 4;12:e56475. doi: 10.2196/56475.
4
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.晚期卵巢上皮癌初始治疗中化疗与手术的比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD005343. doi: 10.1002/14651858.CD005343.pub3.
5
Perioperative nutrition interventions for women with ovarian cancer.卵巢癌女性的围手术期营养干预措施。
Cochrane Database Syst Rev. 2013 Sep 11;2013(9):CD009884. doi: 10.1002/14651858.CD009884.pub2.
6
Angiogenesis inhibitors for the treatment of ovarian cancer.用于治疗卵巢癌的血管生成抑制剂。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD007930. doi: 10.1002/14651858.CD007930.pub2.
7
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
8
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.早期上皮性卵巢癌的辅助（术后）化疗。
Cochrane Database Syst Rev. 2015 Dec 17;2015(12):CD004706. doi: 10.1002/14651858.CD004706.pub5.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.早期上皮性卵巢癌的辅助（术后）化疗。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD004706. doi: 10.1002/14651858.CD004706.pub2.
本文引用的文献
1
Clarifying Blood Indices in Patients With Ovarian Cancer.阐明卵巢癌患者的血液指标
JMIR Mhealth Uhealth. 2025 Aug 13;13:e70895. doi: 10.2196/70895.
2
Efficacy of a WeChat-Based, Multidisciplinary, Full-Course Nutritional Management Program on the Nutritional Status of Patients With Ovarian Cancer Undergoing Chemotherapy: Randomized Controlled Trial.基于微信的多学科全程营养管理方案对化疗卵巢癌患者营养状况的影响：随机对照试验。
JMIR Mhealth Uhealth. 2024 Nov 4;12:e56475. doi: 10.2196/56475.
3
The impact of myelosuppression on quality of life of patients treated with chemotherapy.化疗所致骨髓抑制对患者生活质量的影响。
Future Oncol. 2024;20(21):1515-1530. doi: 10.2217/fon-2023-0513. Epub 2024 Apr 8.
4
Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage.美国预防性使用培非格司亭治疗化疗引起的中性粒细胞减少症：对现有使用指南的依从性评估。
Cancer Treat Res Commun. 2021;29:100466. doi: 10.1016/j.ctarc.2021.100466. Epub 2021 Sep 25.
5
Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.成人癌症患者接受细胞毒化疗后的血小板减少症：一项回顾性基于医院的队列研究结果。
Drug Saf. 2011 Dec 1;34(12):1151-60. doi: 10.2165/11594310-000000000-00000.
Zotero 插件